Skip to content
  • Wednesday, 14 October 2026
  • 11:49 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Johnson and Johnson Raises 2026 Guidance for Sales and Earnings Despite Generic Headwinds and Major Legal and Acquisition Outlays
Pharmaceutical R&D

Johnson and Johnson Raises 2026 Guidance for Sales and Earnings Despite Generic Headwinds and Major Legal and Acquisition Outlays

Teuku Ryan Oct 14, 2026 0

Johnson & Johnson has officially raised its financial projections for the full year 2026, demonstrating remarkable resilience in the face…

Read More
Yale University Research Reveals Significant Cognitive and Physical Gains Among Older Adults Challenging Conventional Views on Aging10 GitHub Repositories for Modern Database Systems and Tools – KDnuggetsOak Ridge National Laboratory Develops RidgeAlloy to Transform Recycled Automotive Scrap into High-Performance Structural ComponentsUnlocking the Secrets of Red Lettuce Pigmentation: Gene Editing Reveals Flavonoid Pathways and Future Cultivation Potential
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic Proportions
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.Navigating the 2026 AI Landscape: Ten Essential Hugging Face Models for Machine Learning PractitionersScience News: A Century of Commitment to Scientific Literacy and Public EngagementPfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
Lana Keisha Oct 14, 2026
Data Science & Bioinformatics
Navigating the 2026 AI Landscape: Ten Essential Hugging Face Models for Machine Learning Practitioners
Evan Lee Salim Oct 14, 2026
Environmental & Analytical Chemistry
Science News: A Century of Commitment to Scientific Literacy and Public Engagement
Abdurrohim Arsyad Oct 14, 2026
Pharmaceutical R&D
Pfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership
Teuku Ryan Oct 14, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ